Fresenius Medical Care AG (FMS) Current Deferred Revenue (2022)

Fresenius Medical Care AG's Current Deferred Revenue history runs 8 years deep, the most recent figure standing at $131.7 million for Q4 2025.

• In Q4 2025, Current Deferred Revenue rose 84.7% year-over-year to $131.7 million; the TTM figure through Dec 2025 stood at $131.7 million (up 84.7% YoY), while the FY2025 annual figure was $131.7 million, up 84.7% from the prior year.
• Current Deferred Revenue for Q4 2025 stood at $131.7 million, up from $71.3 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $1.1 billion in Q1 2021, with the low at $16.5 million in Q3 2022.
• The 5-year median for Current Deferred Revenue is $131.7 million (2025), against an average of $305.7 million.
• The sharpest annual moves came in 2022 and 2025: Current Deferred Revenue plunged 97.4% in 2022, then surged 84.7% in 2025.
• Fresenius Medical Care AG's Current Deferred Revenue stood at $489.7 million in 2021, then tumbled by 86.82% to $64.6 million in 2022, then dropped by 5.72% to $60.9 million in 2023, then grew by 17.17% to $71.3 million in 2024, then soared by 84.7% to $131.7 million in 2025.
• Business Quant data shows FMS's Current Deferred Revenue at $131.7 million in Q4 2025, $71.3 million in Q4 2024, and $79.8 million in Q2 2024.